RJ Reynolds Denied Retrial for Vaping Patent Infringement Case

Jan.16.2023
RJ Reynolds Denied Retrial for Vaping Patent Infringement Case
RJ Reynolds Vapor Co. denied new trial for $95M payment to Altria over Vuse Alto vape pod patent infringement.

RJ Reynolds Vapor Co. has been denied a request to have their September loss reevaluated after being ordered to pay $95 million in damages to Altria Group for violating three vape pod patents with their Vuse Alto electronic cigarettes.


According to reports, Judge N. Carlton Tilley Jr. stated in an opinion released on Thursday in the U.S. District Court for the Middle District of North Carolina that "the jury's disagreement with Reynolds' perspective does not mean the trial was unfair.


Tilley refused the motion made by Reynolds, a subsidiary of BAT, to either retry or reduce the compensation awarded to Altria's customer service company by the jury on September 7th.


In its request for a retrial, Reynolds Vaper argues that "Altria improperly injected provocative evidence regarding allegations of patent infringement against Reynolds in other cases, depriving Reynolds of a fair trial. The erroneous evidence ruling also harmed Reynolds' defense. These errors, taken independently and under the cumulative error doctrine, affected the verdict and thus require a complete retrial.


Altria stated that "this was a fair trial. There is no reason for a retrial, and we are pleased that the jury correctly determined that Reynolds Vapor Company infringed on some of our patents.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

2Firsts’ Nine Global Turning Points: How 2025 Reshaped the Nicotine Industry
2Firsts’ Nine Global Turning Points: How 2025 Reshaped the Nicotine Industry
In 2025, the global nicotine industry reached a critical turning point. Regulatory realignment, category shifts, capital repositioning and technological intervention unfolded in parallel, loosening old structures while new ones took shape. 2Firsts reviews nine pivotal events that reshaped the industry’s trajectory.
Jan.14
2Firsts “Decisive 2026” Concludes: Reviewing the 2025 U.S. Market and Mapping Compliance Pathways Ahead
2Firsts “Decisive 2026” Concludes: Reviewing the 2025 U.S. Market and Mapping Compliance Pathways Ahead
2Firsts hosted “Decisive 2026” in Shenzhen, bringing together industry perspectives to examine major shifts in the U.S. new tobacco market in 2025 and their global implications. Sessions covered U.S. market dynamics, technical insights from recently PMTA-authorized products, an investor lens on tobacco capital markets, and 2025 news/product highlights. The event underscored a structural shift from “gray business” toward compliance and sustainable growth, expected to become clearer by 2026.
Jan.09
Product | 2Firsts Exclusive: Breaking Down Pachamama 25K, CHUC’s First U.S.-Made Factory Product
Product | 2Firsts Exclusive: Breaking Down Pachamama 25K, CHUC’s First U.S.-Made Factory Product
U.S. e-cigarette company Charlie’s has brought its first domestic manufacturing facility online, launching the disposable Pachamama 25K, which will initially roll out to 300 retail stores in Texas. The device features a 20 ml e-liquid capacity with 5% nicotine, three power modes and a built-in 1000 mAh battery, and is advertised to deliver up to 25,000 puffs.
Dec.02 by 2FIRSTS.ai
Exclusive: Altria Confirms FDA Grants Marketing Authorization to on! PLUS, Ending More Than a Year of PMTA Review
Exclusive: Altria Confirms FDA Grants Marketing Authorization to on! PLUS, Ending More Than a Year of PMTA Review
Altria on December 19 confirmed that six on! PLUS nicotine pouch products had received U.S. FDA marketing authorization, ending a PMTA review lasting more than a year after the company moved ahead with launch plans before clearance.
Regulations
Dec.20
FDA Rolls Out Online PMTA Platform, a Move That 2Firsts Analysts Say Could Pull Grey-Market Products Toward Formal Compliance
FDA Rolls Out Online PMTA Platform, a Move That 2Firsts Analysts Say Could Pull Grey-Market Products Toward Formal Compliance
FDA’s launch of a web-based PMTA system signals faster reviews and, 2Firsts experts say, a possible inflection point for the U.S. e-cigarette market’s shift out of the grey zone.
Dec.04
Juul Labs UK launches JUUL2 Peach flavour aimed at adult smokers
Juul Labs UK launches JUUL2 Peach flavour aimed at adult smokers
Juul Labs UK announced on January 1, 2026 the launch of a new JUUL2 Peach flavour, described as an adult-oriented addition that expands the JUUL2 flavour portfolio. The company said the flavour will roll out across the UK from January 1 through major retailers, wholesalers and convenience stores, offering adult smokers alternatives to transition away from cigarettes.
Jan.04 by 2FIRSTS.ai